-+ 0.00%
-+ 0.00%
-+ 0.00%

Corcept Therapeutics Chief Executive Officer Joseph K. Belanoff disposes of 26,198 common shares; value $1,312,000

Reuters·03/27/2026 20:28:38

Please log in to view news